Multiple mitochondrial components generate reactive oxygen species (ROS), but separating the consequences of each ROS-generating source from overall mitochondrial health is challenging. A new class of small-molecule inhibitors that selectively block ROS generation from one of the most active sources may provide a new approach toward achieving that goal.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Orr, A.L. et al. Nat. Chem. Biol. 11, 834–836 (2015).
Murphy, M.P. Biochem. J. 417, 1–13 (2009).
Dickinson, B.C. & Chang, C.J. Nat. Chem. Biol. 7, 504–511 (2011).
Harman, D. J. Am. Geriatr. Soc. 20, 145–147 (1972).
Collins, Y. et al. J. Cell Sci. 125, 801–806 (2012).
Paulsen, C.E. & Carroll, K.S. ACS Chem. Biol. 5, 47–62 (2010).
Murphy, M.P. & Smith, R.A. Annu. Rev. Pharmacol. Toxicol. 47, 629–656 (2007).
Schriner, S.E. et al. Science 308, 1909–1911 (2005).
St-Pierre, J., Buckingham, J.A., Roebuck, S.J. & Brand, M.D. J. Biol. Chem. 277, 44784–44790 (2002).
Jung, H.J. et al. J. Biol. Chem. 285, 11584–11595 (2010).
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Dickinson, B. Plugging the leak. Nat Chem Biol 11, 831–832 (2015). https://doi.org/10.1038/nchembio.1934